Life ScienceCompany
Concert Pharmaceuticals - CTP-656 Ownership
Who owns Concert Pharmaceuticals - CTP-656?
Concert Pharmaceuticals - CTP-656 is owned by Vertex Pharmaceuticals. It was acquired on March 6, 2017.
Concert Pharmaceuticals - CTP-656 Business Overview
Where is Concert Pharmaceuticals - CTP-656 headquartered?
Concert Pharmaceuticals - CTP-656 is headquartered in Lexington, Massachusetts.
What sector is Concert Pharmaceuticals - CTP-656 in?
Concert Pharmaceuticals - CTP-656 is a life science company.
Life Science M&A Summary in 2017
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.
Join Mergr to view all 249 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 226 by strategics.